Tenofovir-associated acute and chronic kidney disease: a case of multiple drug interactions. - Wikidata - wikimedia - TriplyDB

Tenofovir-associated acute and chronic kidney disease: a case of multiple drug interactions.

Tenofovir-associated acute and chronic kidney disease: a case of multiple drug interactions.

http://www.wikidata.org/entity/Q36342389

about

Antiviral drugs for viruses other than human immunodeficiency virus In vitro cytotoxicity and mitochondrial toxicity of tenofovir alone and in combination with other antiretrovirals in human renal proximal tubule cells The Molecular and Structural Basis of HBV-resistance to Nucleos(t)ide Analogs Tenofovir effect on the kidneys of HIV-infected patients: a double-edged sword?Epidemiology, clinical characteristics, and management of chronic kidney disease in human immunodeficiency virus-infected patients Optimal timing and duration of induction therapy for HIV-1 infection An analysis of enzyme kinetics data for mitochondrial DNA strand termination by nucleoside reverse transcription inhibitors A Single-Nucleotide Polymorphism in ABCC4 Is Associated with Tenofovir-Related Beta2-Microglobulinuria in Thai Patients with HIV-1 Infection Risk of Chronic Kidney Disease among Patients Developing Mild Renal Impairment during Tenofovir-Containing Antiretroviral Treatment Prevalence and factors associated with renal dysfunction among HIV-infected patients Screening for chronic kidney disease in HIV-infected patients.COHORT PROFILE: The Complications of Long-Term Antiretroviral Therapy study in Uganda (CoLTART), a prospective clinical cohort.Tenofovir renal proximal tubular toxicity is regulated by OAT1 and MRP4 transporters Renal function in HIV-infected children and adolescents treated with tenofovir disoproxil fumarate and protease inhibitors Renal events among women treated with tenofovir/emtricitabine in combination with either lopinavir/ritonavir or nevirapine Total protein, albumin and low-molecular-weight protein excretion in HIV-positive patients.Renal impairment after switching from stavudine/lamivudine to tenofovir/lamivudine in NNRTI-based antiretroviral regimens Tenofovir disoproxil fumarate for the treatment of HIV infection.Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America.Impact of a tenofovir disoproxil fumarate plus ritonavir-boosted protease inhibitor-based regimen on renal function in HIV-infected individuals: a prospective, multicenter study.Development of diagnostic criteria for serious non-AIDS events in HIV clinical trials.THE RISKS OF CONCURRENT TREATMENT WITH TENOFOVIR AND AMINOGLYCOSIDES IN PATIENTS WITH HIV-ASSOCIATED TUBERCULOSIS.Tenofovir-associated renal dysfunction in clinical practice: An observational cohort from western India Assessment of the role of renal organic anion transporters in drug-induced nephrotoxicity.Nephrotoxicity of HAART Acute renal injury in a 14-year-old with HIV/AIDS and tuberculosis Promising prevention approaches: tenofovir gel and prophylactic use of antiretroviral medications.Renal Function Recovery and HIV Viral Suppression Following Tenofovir Discontinuation for Renal Impairment.Proximal tubular dysfunction and kidney injury associated with tenofovir in HIV patients: a case series.New option for management of HIV-1 infection in treatment-naive patients: once-daily, fixed-dose combination of rilpivirine-emtricitabine-tenofovir.Elevation of Non-Classical (CD14+/lowCD16++) Monocytes Is Associated with Increased Albuminuria and Urine TGF-β1 in HIV-Infected Individuals on Stable Antiretroviral Therapy.Hypophosphatemic Osteomalacia Associated with Tenofovir: a Multidisciplinary Approach is Required.Efficacy, adherence and tolerability of once daily tenofovir DF-containing antiretroviral therapy in former injecting drug users with HIV-1 receiving opiate treatment: results of a 48-week open-label study Antiretroviral therapy and the kidney: balancing benefit and risk in patients with HIV infection.The impact of impaired kidney function and HIV infection on the risk of anemia.HIV-associated renal diseases and highly active antiretroviral therapy-induced nephropathy.Is Abnormal Urine Protein/Osmolality Ratio Associated with Abnormal Renal Function in Patients Receiving Tenofovir Disoproxil Fumarate?Acute renal failure in an AIDS patient on tenofovir: a case report.Relationship between renal dysfunction, nephrotoxicity and death among HIV adults on tenofovir.Brief Report: Switch to Ritonavir-Boosted Atazanavir Plus Raltegravir in Virologically Suppressed Patients With HIV-1 Infection: A Randomized Pilot Study.

P2860

Q24635330-ECBBD50A-66BF-488D-9D32-C4374AE87F64 Q24674939-0F40FDD6-7DB0-4C04-85E3-6C92A8720590 Q26781795-3D46BAB6-180E-4D93-9264-75188D81BE45 Q26995852-8EDB4E3D-1AF0-4051-9120-8149BFD95992 Q27009523-3D883362-C3A1-4BB6-A3AA-EFAB3E5656EF Q28469250-4FA8738A-70A6-4105-AAE3-49FA29625A58 Q28474361-29C71C96-5DD8-44BA-8A8B-A68CD27F3A62 Q28552839-154EEDA9-9ED5-4012-A96B-A6809FA2C9E1 Q28554081-C3AEBE23-6C2B-4799-AB70-35E65A5E5B46 Q30484533-989C6402-77D9-4CC8-813A-B7D13C4CB25B Q33639802-ED77C18C-941F-4FAF-8C31-3682DFCC2BD1 Q33640397-518E80CD-BA55-4221-9917-FCED1597D3C2 Q33845879-0FE9B1AC-D3D3-4820-8D39-1F22BDCF0815 Q34136166-EC16F5AE-1474-4A43-9378-195BFC4F252A Q34250879-33A5D6C7-D402-4716-ABB1-1857AFCFEF01 Q34375843-C53997D2-8598-4B8C-B862-C430D78D0657 Q34488494-A483AE2B-4CE0-415F-922A-CAF41B16A4E7 Q34569309-6A880B6D-B5E1-4D2D-A223-01CDBD9EB6C5 Q34736194-D6C820BB-C831-4679-A481-EDB43EDE7340 Q34787977-C6CD4705-AE80-4B61-B6AA-DD1ABF0A12C1 Q35030752-889546E4-32FF-4D5E-AC9F-D636D6ED4FE9 Q35054462-CACDB176-0F95-44E3-91A9-AA117D097B9A Q35117296-102357C5-2721-4CE2-B774-C6BB20C8359C Q35155913-ED56C911-A4A6-46A1-B1DE-B9546D519A56 Q35167944-5EFD78ED-831C-476C-85D7-C4EEB0E8BEC1 Q35535325-CD515786-0845-45EC-9125-9865C8999F8D Q35619304-4623FDDF-029D-44E6-AC13-5568ECD40D78 Q35748339-DA756EB0-55D7-4497-9745-7FE6824F8829 Q35891568-E9509AC2-24EA-4E54-A668-23F420DD6DD9 Q35939695-8A11EA0D-644E-40D4-B0C2-C84DAD5C14BD Q35994939-B1A33B58-2E81-48D1-ADF0-618CDD890A34 Q36033710-2A0B88C0-F4D5-4E3C-B812-AC618D502395 Q36105831-4CF950B9-B5FD-43B5-8C54-1627BAFE199A Q36407276-2E187335-26E3-4379-8E00-894256DADF93 Q36419540-D2F43617-DEAD-425F-9850-FDB9E847FE82 Q36451062-ABC32196-6BC2-4162-8425-6A24E3306208 Q36576316-DDD6C095-D47C-4606-9E0E-242E8E6ECDEB Q36579269-8209AD50-AA67-47D8-B905-40CA594DE84B Q36651106-D312F374-9FFF-4DBC-9D4F-7BB9CAD5E720 Q36721002-2F996B5F-9E42-4911-96B6-FDF055584A46

P2860

Tenofovir-associated acute and chronic kidney disease: a case of multiple drug interactions.

http://www.wikidata.org/entity/Q36342389

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Tenofovir-associated acute and ...... of multiple drug interactions.

@ast

Tenofovir-associated acute and ...... of multiple drug interactions.

@en

type

label

Tenofovir-associated acute and ...... of multiple drug interactions.

@ast

Tenofovir-associated acute and ...... of multiple drug interactions.

@en

prefLabel

Tenofovir-associated acute and ...... of multiple drug interactions.

@ast

Tenofovir-associated acute and ...... of multiple drug interactions.

@en

P1433

Q36342389-121B92AC-2A99-4AC9-A5B3-C91BD9A4DE57

P1476

Q36342389-4B739FB2-7ABB-4E39-8181-6625F5C19D18

P2093

Q36342389-3FDBC619-27E6-41F4-AA64-FE389F2C4B13

Q36342389-4E3C5D06-DAB4-45BB-80C8-C97D1CC61C3E

Q36342389-58EAA7A9-82D8-4E80-B82F-1A6315C0B297

Q36342389-5EED4474-1A34-43AE-831B-1A445F15445F

Q36342389-643D3739-3AB4-44AD-9AFC-21001CEC8207

Q36342389-F2BB2AE4-025E-4B77-973A-E6765BAB2C36

P2860

Q36342389-0338A19F-FD46-4558-8EDA-9E7DE6C43475

Q36342389-12A36852-568C-4E07-8A07-9FC0D348E7C1

Q36342389-176B6F82-42EE-4EC2-AFF5-DA417A8AA059

Q36342389-3AC6CE0B-5309-49AA-A372-A0664DB8102E

Q36342389-3BD6302C-FFF6-4FC4-94B7-69A07692FF81

Q36342389-45674DF4-F499-40AD-88C1-02E52E06CD54

Q36342389-48C204AE-2BED-4C62-8B2E-20A59C7B5DBE

Q36342389-70E3AE31-7527-4139-9301-08FE52B27678

Q36342389-7CF14EB0-BE7B-48EF-B5F8-F5A5952E5B6D

Q36342389-86FABDC6-C5FC-41BE-9481-D36E05EAD729

P304

Q36342389-B15910CA-C881-452B-BEA8-B688D8B83F71

P31

Q36342389-90E850F7-5177-4080-B3D4-48EA39AB22B0

P356

Q36342389-42DEB5D6-F3D6-4B36-AF1A-A8360D890F35

P407

Q36342389-793EB691-4B7B-45A2-BA45-43330B3BA6BA

P433

Q36342389-931D0875-6671-41CD-AE75-E1C2F456FBD2

P478

Q36342389-83CD6B78-D16E-432B-8FC4-72472839FEE6

P577

Q36342389-FA869C9B-3A04-4E9A-A374-6F249D7C4EF5

P698

Q36342389-5BA0C323-1DF4-484D-B92B-5F29252896F9

P356

P1433

Clinical Infectious Diseases

P1476

Tenofovir-associated acute and ...... of multiple drug interactions.

@en

P2093

Anne Morris

http://www.w3.org/2001/XMLSchema#string

Anthony E Zimmermann

http://www.w3.org/2001/XMLSchema#string

Gregory Braden

http://www.w3.org/2001/XMLSchema#string

John Bedford

http://www.w3.org/2001/XMLSchema#string

Robert Hoffman

http://www.w3.org/2001/XMLSchema#string

Thomas Pizzoferrato

http://www.w3.org/2001/XMLSchema#string

P2860

Assessment of mitochondrial toxicity in human cells treated with tenofovir: comparison with other nucleoside reverse transcriptase inhibitors

Renal tubular dysfunction associated with tenofovir therapy: report of 7 cases

Frequency of urolithiasis in individuals seropositive for human immunodeficiency virus treated with indinavir is higher than previously assumed

Cidofovir-induced end-stage renal failure

Tenofovir-related Fanconi syndrome with nephrogenic diabetes insipidus in a patient with acquired immunodeficiency syndrome: the role of lopinavir-ritonavir-didanosine.

The safety and efficacy of adefovir dipivoxil in patients with advanced HIV disease: a randomized, placebo-controlled trial.

Interactions between atazanavir-ritonavir and tenofovir in heavily pretreated human immunodeficiency virus-infected patients

Disposition of didanosine in HIV-seropositive patients with normal renal function or chronic renal failure: influence of hemodialysis and continuous ambulatory peritoneal dialysis.

Drug-induced Fanconi's syndrome.

Atazanavir: effects on P-glycoprotein transport and CYP3A metabolism in vitro.

P304

283-290

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/499048

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P577

2005-12-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16355343

http://www.w3.org/2001/XMLSchema#string